It pays to be prepared, especially in uncertain times. As sites struggle to maintain patient visits and keep trials moving forward amidst COVID-19, many are turning to remote monitoring and other elements of decentralized clinical trials (DCTs) to ensure their doors stay open. This SCRS Talks interview with Global Impact Partner (GIP) VirTrial provides insight into how sites can prepare to participate in DCTs or incorporate virtual visits into their trials. Listen in as VirTrial’s Director of Business Development, Emil Hoeck, discusses industry trends related to COVID-19, identifies best practices for going virtual to support your site’s sustainability, and addresses why now is the time to become virtual trial capable.